Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2026-01-12 00:00:00 ET · period of report 2026-01-08 · accession 0001193125-26-010699 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-12 | 2026-01-08 | GMED | Kline Kyle | SVP, CFO | M - OptEx | $51.87 | +3,594 | 3,594 | New | +$186.4K |
| DT | 2026-01-12 | 2026-01-08 | GMED | Kline Kyle | SVP, CFO | S - Sale+OE | $101.10 | -3,594 | 0 | -100% | -$363.4K |
| DT | 2026-01-12 | 2026-01-08 | GMED | Kline Kyle | SVP, CFO | M - OptEx | $0.00 | -3,594 | 3,906 | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-01-08 | M | A | 3,594 | $51.87 | 3,594 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-01-08 | S | D | 3,594 | $101.10 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2026-01-08 | M | D | 3,594 | $0.00 | 3,906 | D | $51.87 · — to 2034-03-14 | 3,594 Class A Common Stock | (F2) These options were granted on March 14, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |